FDA Inspection 1121556 — Gulf Coast Regional Blood Center

Gulf Coast Regional Blood Center — FEI 3003949974

The FDA completed an inspection of Gulf Coast Regional Blood Center on January 31, 2020 in Houston, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
January 31, 2020
Fiscal Year
2020
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Houston, TX (United States)